ARIH2P1

Across TCGA pan-cancer cohorts, ARIH2P1 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated ARIH2P1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher ARIH2P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ARIH2P1 expression acts as an unfavorable survival marker, although some lineages such as PAAD and SKCM show a favorable association.

ACC, KICH, and PAAD are the cancer types where ARIH2P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	II,III,IV	0.293	0.705	.004	43	view →
KICH	DFS	Tertile	All	0.813	1.000	.012	30	view →
PAAD	OS	Median	All	0.769	0.525	.001	29	view →
LGG	OS	Median	All	0.760	0.855	.001	28	view →
BRCA	DFS	Quartile	All	0.871	0.935	.001	27	view →
SKCM	OS	Quartile	II,III,IV	0.453	0.190	.002	22	view →
CESC	OS	Median	IV	0.088	0.542	.004	18	view →
LUSC	OS	Quartile	II,III,IV	0.398	0.883	<.001	18	view →
THCA	DFS	Median	All	0.894	0.768	.002	16	view →
DLBC	DFS	Tertile	IV	0.923	0.191	.010	14	view →
ESCA	OS	Tertile	IV	0.916	0.219	.024	12	view →
GBM	DFS	Median	All	0.392	0.186	.002	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

ARIH2P1–ACC (DFS)

Open the ACC breakdown →